Moayed Ben Moftah - Profile and Journalist Details
Find journalists that align with your industry, location and vision. Unlock Moayed Ben Moftah's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.
Get connected with journalists todayMoayed Ben Moftah
Verified
Author, Freelance
Tripoli
Beats
Biography
Pharmaceutical scientist with passion for cancer therapeutics, clinical immunology, molecular biology, and pharmaceutical theories and hypotheses. Author of scientific publications and reviewer for Elsevier. Pharmaceutical researcher at the university of Shizuoka, Japan.
Clinical Pharmacy and Molecular Biology
politics, scandal
Content
By Hermann Mucke, Moayed Ben Moftah, Asma Eswayah, A. Alper Öztürk| Mary Ann Liebert, Inc.@ Editor-in-Chief: Bruce J. Melancon, PhDASSAY and Drug Development Technologies is proud to highlight this virtual collection dedicated to COVID-19 drug repurposing, drug development, and drug discovery peer-reviewed content. We are honored to present this research free to access through June 30, 2022. Are you working on drug repurposing, drug development, or drug discovery COVID-19 research? Submit your work today!
By Moayed Ben Moftah, Asma Eswayah| Mary Ann Liebert, Inc.@ INTRODUCTION The World Health Organization (WHO) declared the COVID-19 outbreak as the sixth public health emergency of global concern, after the H1N1 (2009), Polio (outbreak in previously declared polio-free countries, 2014), Ebola (West Africa, 2014; Democratic Republic of Congo, 2019), and Zika (2016) outbreaks.1 The pandemic situation that the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has created is of intricate nature; currently, no approved therapeutic or...
Company Info
Freelance
Freelancer.com is the largest freelancing and crowdsourcing marketplace in the world, connecting over 81 million employers and freelancers across more than 247 countries. Founded in 2009 and based in Sydney, Australia, the platform allows employers to post jobs while freelancers can bid on these projects. It is publicly traded on the Australian Securities Exchange under the ticker ASX:FLN. The platform supports a variety of work categories, including software development, writing, design, and marketing. Freelancer.com also offers contests for creative work, where employers can award prize money to winning entries. Users can choose from different membership plans, including free and paid subscriptions, which provide various benefits. The mobile app enhances project management and communication for users on the go. With a diverse customer base that includes individuals, small businesses, and large enterprises, Freelancer.com plays a significant role in the global online economy.
De Pere, Wisconsin, United States